Lakhmir Chawla, MD, is a nephrologist and critical care physician. He serves as CEO of Stavro Medical and Clinical Professor of Medicine at the University of California, San Diego Medical Center, and sits on the Board of Directors of Revelation Biosciences. His clinical focus spans critical care nephrology, hemodynamic resuscitation and organ support, and extracorporeal therapies. His research centers on biomarkers and risk prediction, organ–kidney crosstalk and recovery, and translational drug and device development for the intensive care setting. He received the International Vicenza Award for Critical Care Nephrology and has held leadership roles including Chief of the Division of Intensive Care Medicine at the Washington D.C. Veterans Affairs Medical Center, Professor of Medicine at George Washington University, Chief Medical Officer at La Jolla Pharmaceutical Company and Silver Creek Pharma, Scientific Advisor to ExThera Medical, and Associate Editor for the Clinical Journal of the American Society of Nephrology. Chawla earned his medical degree from Rutgers New Jersey Medical School and completed residency at George Washington University Hospital.
Private Practice
Medical School
1991 – 1995
Residency
1995 – present
Fellowship